Leading science, pioneering therapies

CRM Publications

Type a few characters, select from list

2009

Kung JWC, Forbes SJ.  2009.  Stem cells and liver repair.Curr Opin Biotechnol. 20(5):568-74.
Hu Y, Guimond SE, Travers P, Cadman S, Hohenester E, Turnbull JE, Kim S-H, Bouloux P-M.  2009.  Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.J Biol Chem. 284(43):29905-20.
Mills NL, Tura O, Padfield GJ, Millar C, Lang NN, Stirling D, Ludlam C, Turner ML, Barclay GR, Newby DE.  2009.  Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention.Heart. 95(24):2003-8.
Marthiens V, ffrench-Constant C.  2009.  Adherens junction domains are split by asymmetric division of embryonic neural stem cells.EMBO Rep. 10(5):515-20.
Hunt DPJ, Jahoda C, Chandran S.  2009.  Multipotent skin-derived precursors: from biology to clinical translation.Curr Opin Biotechnol. 20(5):522-30.
Tzouanacou E, Wegener A, Wymeersch FJ, Wilson V, Nicolas J-F.  2009.  Redefining the progression of lineage segregations during mammalian embryogenesis by clonal analysis.Dev Cell. 17(3):365-76.
Livigni A, Villegas SNahuel, Oikonomopoulou I, Rahman A, Morrison GM, Brickman JM.  2009.  Differentiation of embryonic stem cells into anterior definitive endoderm.Curr Protoc Stem Cell Biol. Chapter 1:Unit1G.3.
Bauer NG, Richter-Landsberg C, ffrench-Constant C.  2009.  Role of the oligodendroglial cytoskeleton in differentiation and myelination.Glia. 57(16):1691-705.
Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsenstein M et al..  2009.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.Nature. 458(7239):766-70.
Jones M, Peden AH, Yull H, Wight D, Bishop MT, Prowse CV, Turner ML, Ironside JW, MacGregor IR, Head MW.  2009.  Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease.Transfusion. 49(2):376-84.
O'Malley J, Woltjen K, Kaji K.  2009.  New strategies to generate induced pluripotent stem cells.Curr Opin Biotechnol. 20(5):516-21.
Kallis YN, Forbes SJ.  2009.  The bone marrow and liver fibrosis: friend or foe?Gastroenterology. 137(4):1218-21.
Dalgetty D, Medine C.N, Iredale JP, Hay DC.  2009.  Progress and future challenges in stem cell-derived liver technologies.Am J Physiol Gastrointest Liver Physiol. 297(2):G241-8.
de Sousa P, Gardner J, Sneddon S, Pells S, Tye BJorgensen, Dand P, Collins DM, Stewart K, Shaw L, Przyborski S et al..  2009.  Clinically failed eggs as a source of normal human embryo stem cells.Stem Cell Res. 2(3):188-97.
Baer AS, Syed YA, Kang SUng, Mitteregger D, Vig R, ffrench-Constant C, Franklin RJM, Altmann F, Lubec G, Kotter MR.  2009.  Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling.Brain. 132(Pt 2):465-81.
Chandran S, Naughton GK.  2009.  Tissue, cell and pathway engineering.Curr Opin Biotechnol. 20(5):509-10.
Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, Barrandon O, Wray J, Yamanaka S, Chambers I, Smith A.  2009.  Nanog is the gateway to the pluripotent ground state.Cell. 138(4):722-37.
Tsakiridis A, Tzouanacou E, Rahman A, Colby D, Axton RA, Chambers I, Wilson V, Forrester LM, Brickman JM.  2009.  Expression-independent gene trap vectors for random and targeted mutagenesis in embryonic stem cells.Nucleic Acids Res. 37(19):e129.
Chambers I, Tomlinson SR.  2009.  The transcriptional foundation of pluripotency.Development. 136(14):2311-22.

Pages